1425 related articles for article (PubMed ID: 30134231)
1. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
2. PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2.
Zhao FY; Xu SL; Zhang CF; Liu J; Zhang Y; Yang J; Xing XQ
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179105
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells.
Wang C; Li JF; Zhao L; Liu J; Wan J; Wang YX; Wang J; Wang C
Respir Res; 2009 Dec; 10(1):123. PubMed ID: 20003325
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil inhibits calcineurin/NFATc2-mediated cyclin A expression in pulmonary artery smooth muscle cells.
Li M; Liu Y; Sun X; Li Z; Liu Y; Fang P; He P; Shi H; Xie M; Wang X; Zhang D; Zhang Y; Ming Z; Xu J; Lu J; Xie X
Life Sci; 2011 Oct; 89(17-18):644-9. PubMed ID: 21851826
[TBL] [Abstract][Full Text] [Related]
6. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
7. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
[TBL] [Abstract][Full Text] [Related]
8. S1P induces pulmonary artery smooth muscle cell proliferation by activating calcineurin/NFAT/OPN signaling pathway.
Yan X; Wang J; Zhu Y; Feng W; Zhai C; Liu L; Shi W; Wang Q; Zhang Q; Chai L; Li M
Biochem Biophys Res Commun; 2019 Aug; 516(3):921-927. PubMed ID: 31277946
[TBL] [Abstract][Full Text] [Related]
9. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
10. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
[TBL] [Abstract][Full Text] [Related]
13. NFATc3 pathway participates in the process that 15-LO/15-HETE protects pulmonary artery smooth muscle cells against apoptosis during hypoxia.
Ran Y; Wu H; Wei L; Yu X; Chen J; Li S; Zhang L; Lou J; Zhu D
J Recept Signal Transduct Res; 2014 Aug; 34(4):270-82. PubMed ID: 24853029
[TBL] [Abstract][Full Text] [Related]
14. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B; Le Ribeuz H; Sabourin J; Laubry L; Woodhouse E; Foster R; Ruchon Y; Dutheil M; Boët A; Ghigna MR; De Montpreville VT; Mercier O; Beech DJ; Benitah JP; Bailey MA; Humbert M; Montani D; Capuano V; Antigny F
Circ Res; 2022 Oct; 131(9):e102-e119. PubMed ID: 36164973
[TBL] [Abstract][Full Text] [Related]
15. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
16. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.
Bai Y; Li ZX; Wang HL; Lian GC; Wang Y
Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
[TBL] [Abstract][Full Text] [Related]
18. [Calcineurin/NFAT signaling pathway mediates endothelin-1-induced pulmonary artery smooth muscle cell proliferation by regulating phosphodiesterase-5].
Lu J; Wang X; Xie X; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):26-9. PubMed ID: 23353150
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
20. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
